Jorge C S, Artal R, Paul R H, Goebelsmann U, Gratacós J, Yeh S Y, Golde S H, Mestman J H
Am J Obstet Gynecol. 1981 Nov 15;141(6):641-5. doi: 10.1016/s0002-9378(15)33304-4.
The antepartum fetal surveillance (biochemical and biophysical) data of 140 pregnant diabetic patients were evaluated. We determined how often intervention occurred on the basis of abnormal tests and correlated each test with neonatal outcome. Fifteen of the total 140 patients had their pregnancies terminated because of abnormal biochemical and/or biophysical tests. An abnormal estriol (E3) value preceded the abnormal antepartum fetal heart rate testing in eight of 10 instances. We conclude that the major benefit of the antepartum fetal surveillance techniques, in this group of patients and under the present scheme, is in determining when not to intervene, thus allowing safe prolongation of pregnancy.
对140例糖尿病孕妇的产前胎儿监护（生化和生物物理）数据进行了评估。我们根据异常检查确定干预的频率，并将每项检查与新生儿结局相关联。140例患者中有15例因生化和/或生物物理检查异常而终止妊娠。在10例中有8例，雌三醇（E3）值异常先于产前胎儿心率测试异常。我们得出结论，在这组患者以及当前方案下，产前胎儿监护技术的主要益处在于确定何时不进行干预，从而实现安全延长孕期。
